Epidemiology of left ventricular systolic dysfunction in the general population of Germany: Results of an echocardiographic study of a large population-based sample;Epidemiologie der linksventrikulären systolischen dysfunktion in der allgemeinbevölkerung Deutschlands ergebnisse echokardiografischer untersuchungen einer großen bevolkerungsstichprobe

Zeitschrift fur Kardiologie

Volumn 92, Issue 4, 2003, Pages 294-302

  Fischer, M ^b   Baessler, A ^b   Holmer, S R ^b   Muscholl, M ^b   Brockel U ^b   Luchner, A ^b   Hense, H W ^c   Doring A ^d   Riegger, G ^b   Schunkert, H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Echocardiographic screening; Epidemiology; General population; Heart failure; Left ventricular systolic dysfunction; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DEVICE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; GERMANY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OBESITY; PREVALENCE; RISK FACTOR; SCREENING TEST; SYSTOLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; GERMANY; HEALTH SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037884145     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0899-2     Document Type: Article

References (33)

1. Bonneaux L, Barendregt JJ, Meeter K et al (1994) Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future risk of heart failure. Am J Public Health 84:20-28
2. Schunkert H, Broeckel U, Hense H-W, Keil U, Riegger GAJ (1998) Prevalence of left ventricular diastolic dysfunction in the general population. Lancet 351 [letter]
3. Yamamoto K, Burnett JC, Bermudez EA, Jougasaki M, Bailey KR, Redfield MM (2000) Clinical Criteria and biochemical markers for the detection of systolic dysfunction. J Cardiac Fail 6:194-200
4. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:658-691
5. Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Enlargement Trial. N Engl J Med 327:685-691
6. Muscholl M, Hense H-W, Broeckel U, Döring A, Riegger GAJ, Schunkert H (1998) Alterations of left ventricular geometry and function in subjects with white coat hypertension: cross sectional survey. BMJ 317:565-570
7. Kuch B, Hense H, Gneiting B, Döring A, Muscholl M, Bröckel U, Schunkert H (2001) Body composition and prevalence of left ventricular hypertrophy. Circulation 102:405-410
8. Schunkert H, Broeckel U, Hengstenberg C, Luchner A, Muscholl M, Kurzidim K, Kuch B, Döring A, Riegger GAJ, Hense HW (1999) Familial predisposition of left ventricular hypertrophy. J Am Coll Cardiol 33:1685-1691
9. Sahn D, DeMaria A, Kissl J, Weymann A (1978) The committee on M-mode standardization of the American Society of Echocardiography: results on a survey of echocardiographic measurements. Circ 58:1072-1083
10. Devereux RB, Reichek N (1997) Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circ 55:613-618
11. Kannel WB (2000) Vital epidemilogic clues in heart failure. J Clin Epidemiol 53:229-235
12. Ho K, Pinsky J, Kannel W, Levy D (1993) The epidemiology of congestive heart failure: the Framingham Study. J Am Coll Cardiol 22:6A-13A
13. McKee PA, Castelli WD, McNamara PM et al (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 26:1441-1446
14. Effects of enalapril on mortality in severe congestive heart failure (1987) Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316:1429-1435
15. Schocken D, Arieta M, Leaverton P, Ross E (1992) Prevalence and mortality rate of congestive heart failure in the united states. J Am Coll Cardiol 20:301-306
16. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJV, Dargie HJ (1997) Symptomatic and asymptomatic left-ventricular dysfunction in an urban population. Lancet 350:829-833
17. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary death in the World Health Organization MONICA project. Registration procedures, event rates, and case fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583-612
18. Morgan S, Smith H, Simpson I, Liddiard Gs, Raphael H, Pickering RM, Mant D (1999) Prevalence and clinical characteristicsof left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ 318:368-372
19. Talreja D, Gruver C, Sklenar J, Dent J, Kaul S (2000) Effizient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J 139:394-398
20. Cowie M, Mosterd A, Wood D et al (1997) The epidemiology of heart failure. Eur Heart J 18:208-225
21. Cleland J (1997) Screening of left ventricular dysfunction and chronic heart failure: should it be done and if so, how? Dis Management Health Outcomes 1:169-184
22. Packer M, Cohn JN (1999) Consensus recommendations for the management of chronic heart failure. Am J Cardiol 83:2A-77A
23. Armstrong PW, Moe GW (1993) Medical advances in the treatment of congestive heart failure. Circulation 88:2941-2952
24. Cohn JH (1992) The prevention of heart failure-a new agenda (editorial). N Engl J Med 327:725-727
25. Parameshwar J, Shakell MM, Richardson A, Poole-Wilson PA (1992) Prevalence of heart failure in three general practices in north London. Br J Gen Prac 42:287-289
26. Mair FS, Crowley TS, Bundred PE (1996) Prevalence, aetiology and management of heart failure in general pactice. Br J Gen 46:77-79
27. Remes J, Miettinen H, Reunanen A, Pyorälä K (1991) Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12:315-319
28. Mosterd A, Hoes AWDMC, Deckers JW, Linker DT, Hofman A, Grobbee DE (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20447-20455
29. Clerico A, Iervasi G, Chicca M et al (1998) Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immu-noradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 21:170
30. Dao Q, Krishnaswamy P, Kazanegra R et al (2001) Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol 37:379-385
31. McDonagh TA, Robb SD, Murdoch DR et al (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet 351:9-13
32. Cowie MR, Struthers AD, Wood DA et al (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1347-1351
33. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, Levy D (2002) Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288:1252-1259